Cargando…
Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options
BACKGROUND: Patients newly diagnosed with lung adenocarcinoma with bone metastases (LABM) have poor survival rates after treatment with conventional therapies. To improve outcomes, we retrospectively investigated whether the application of a more comprehensive genetic test of tumor biopsies samples...
Autores principales: | Huang, Long, Jiang, Xiao-Liu, Liang, Hong-Bin, Li, Jian-Cheng, Chin, Li-Han, Wei, Jian-Ping, Wang, Rui-Ru, Cai, Jing, Xiong, Qiang, Wang, Lien-Tu, Cram, David S., Liu, An-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499871/ https://www.ncbi.nlm.nih.gov/pubmed/32942985 http://dx.doi.org/10.1186/s10020-020-00197-9 |
Ejemplares similares
-
Mandible Bone Metastases Secondary to Pulmonary Adenocarcinoma
por: Dirican¹, Nigar, et al.
Publicado: (2014) -
Bone Metastases of Gastrointestinal Stromal Tumor: A Review of Published Literature
por: Yang, Jian, et al.
Publicado: (2020) -
PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases
por: Yang, Yanmei, et al.
Publicado: (2018) -
Genetic Heterogeneity Between Paired Primary and Brain Metastases in
Lung Adenocarcinoma
por: Li, Li, et al.
Publicado: (2020) -
Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma
por: Feng, Alei, et al.
Publicado: (2022)